IMI 2021年度文摘:近视研究新进展
文摘重点介绍了前近视定义、病理性近视新定义、新药物干预、336个新遗传位点、多区正向光学离焦眼镜及低浓度阿托品联合角膜塑形镜等进展,并讨论了安慰剂对照伦理、近视降低物理指标与百分比报告、儿童角膜塑形镜佩戴风险及生活质量等议题。
要点
- 前近视定义已用于正在进行的干预研究。
- 病理性近视领域出现新定义。
- 多区正向光学离焦眼镜及低浓度阿托品联合角膜塑形镜为新临床干预。
核心结论
- 自IMI 2019白皮书发布以来,近视领域已发表大量研究,年度文摘旨在突出最新研究与进展。
研究设计与样本
- 对2019年至2020年中期发表的近视相关文章进行文献检索,并考虑同期重要会议摘要,以涵盖定义与分类、实验模型、遗传学、干预、临床试验和临床管理。
主要发现
- 关键进展包括前近视定义用于正在进行的干预研究、病理性近视新定义、降眼压拉坦前列素等新药物在实验模型中的作用、大型屈光不正荟萃分析识别336个新遗传位点。
- 新临床干预包括多区正向光学离焦眼镜及低浓度阿托品联合角膜塑形镜(OK)。
- 讨论了近视控制治疗确立时安慰剂对照组的伦理困境、报告近视降低物理指标与百分比降低、儿童OK佩戴风险与近视视力损害风险的比较、预防近视和眼轴增长与生活质量及未来视力丧失的论证。
关键数值与推荐
- 大型屈光不正荟萃分析识别336个新遗传位点。
临床怎么用
- 临床可关注前近视定义、病理性近视新定义、多区正向光学离焦眼镜及低浓度阿托品联合角膜塑形镜等新干预,并注意近视降低报告方式及儿童角膜塑形镜佩戴风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The International Myopia Institute (IMI) Yearly Digest highlights new research considered to be of importance since the publication of the first series of IMI white papers. METHODS: A literature search was conducted for articles on myopia between 2019 and mid-2020 to inform definitions and classifications, experimental models, genetics, interventions, clinical trials, and clinical management. Conference abstracts from key meetings in the same period were also considered. RESULTS: One thousand articles on myopia have been published between 2019 and mid-2020. Key advances include the use of the definition of premyopia in studies currently under way to test interventions in myopia, new definitions in the field of pathologic myopia, the role of new pharmacologic treatments in experimental models such as intraocular pressure-lowering latanoprost, a large meta-analysis of refractive error identifying 336 new genetic loci, new clinical interventions such as the defocus incorporated multisegment spectacles and combination therapy with low-dose atropine and orthokeratology (OK), normative standards in refractive error, the ethical dilemma of a placebo control group when myopia control treatments are established, reporting the physical metric of myopia reduction versus a percentage reduction, comparison of the risk of pediatric OK wear with risk of vision impairment in myopia, the justification of preventing myopic and axial length increase versus quality of life, and future vision loss. CONCLUSIONS: Large amounts of research in myopia have been published since the IMI 2019 white papers were released. The yearly digest serves to highlight the latest research and advances in myopia.
引用
- Jong M, Jonas JB, Wolffsohn JS, et al. IMI 2021 Yearly Digest. Invest Ophthalmol Vis Sci. 2021. PMID: 33909031. doi:10.1167/iovs.62.5.7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。